Please be aware that Mahajan Imaging & Labs will never request for your bank details or OTP for booking/registration purposes.

What is a Hereditary Prostrate Cancer Panel?

Hereditary Prostate Cancer Panel is a genetic test that analyzes multiple key genes (such as BRCA1, BRCA2, ATM, HOXB13, CHEK2, PALB2, and others) associated with inherited predisposition to prostate cancer. This panel is used to identify germline mutations that increase the lifetime risk of developing prostate cancer, often at a younger age or with more aggressive disease. It helps in risk assessment, early screening recommendations, family counseling, and guiding targeted therapies (e.g., PARP inhibitors) for patients already diagnosed with prostate cancer.

Additional Information

Also known as/ Other names: Prostate Cancer Genetic Panel, Inherited Prostate Cancer Risk Test, Hereditary Cancer Gene Panel for Prostate Cancer, Prostate Cancer Predisposition Panel
Parameters: 1
Recommended for: M/F/Others
Sample Type: Blood
Patient Preparation: Minimum gap from Chemotherapy should be 2 weeks
Reports: 4-6 weeks

FAQs

Which genes are included in this panel?

The panel typically includes BRCA1, BRCA2, ATM, HOXB13, CHEK2, PALB2, and other prostate cancer risk genes.

Why is this Hereditary Prostate Cancer Panel ordered?

It is ordered to assess inherited risk, guide early screening, and help in treatment decisions for prostate cancer.

Who should undergo this genetic panel?

It is recommended for men with family history of prostate cancer, early-onset disease, or aggressive prostate cancer.

What is the risk increase if a mutation is found?

Certain mutations (e.g., BRCA2) can increase lifetime prostate cancer risk up to 2–5 times higher than average.

What is a Variant of Uncertain Significance (VUS)?

A VUS means a genetic change is found but it is unclear whether it increases cancer risk.

Can this test guide prostate cancer treatment?

Certainly, BRCA1/BRCA2 mutations may make patients eligible for targeted therapies like PARP inhibitors.

Does a negative result mean no risk of prostate cancer?

No. A negative result lowers inherited risk but does not eliminate the possibility of sporadic prostate cancer.

Recommend more for you

Book Your Test
Text copied to clipboard
Dynamic badges will be added here